Skip to Content

Press Releases

The information and content in this site has been released in the past by Express Scripts Holding Company or its predecessor and wholly-owned subsidiary, Express Scripts, Inc. (together, Express Scripts). These contents may no longer be current. The passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. On the date released, some of the contents in this site may have contained statements that were then "forward-looking statements," based upon then current expectations, forecasts and assumptions that involved risks and uncertainties, then enumerated by Express Scripts that could cause actual outcomes and results to differ materially. To the extent any information is forward-looking, it is intended to comply with the safe harbor for forward-looking information as of the date of issuance (for more information, view our forward-looking statement). Express Scripts disclaims any intention or obligation to update or revise the contents of this site, including but not limited to any forward-looking statements made at the time the information was first released, whether as a result of new information, future events or otherwise.

Archived Press Releases

Date Title and Summary
Toggle Summary Express Scripts Closes Acquisition Of eviCore; Companies Unite To Improve Healthcare For 100 Million Americans
- Improves ability to attack enormous inefficiencies and address unnecessary spending - Leverages evidence-based medicine, advanced data analytics and clinical specialization to improve care and control cost across pharmacy and medical platforms - Delivers accretion to growth, earnings and cash
Toggle Summary Express Scripts Holding Company Updates 2017 Full-Year Guidance and Announces 2018 Financial Guidance
ST. LOUIS , Dec. 14, 2017 /PRNewswire/ --   Express Scripts Holding Company (Nasdaq: ESRX) increased its previously issued consolidated 2017 full-year adjusted EPS guidance range of $6.97 to $7.05 to $7.00 to $7.08 , which represents growth of 10% over consolidated 2016 adjusted EPS results at the
Toggle Summary Avista Capital Partners to Acquire Express Scripts' Subsidiary United BioSource
ST. LOUIS and NEW YORK , Nov. 27, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) and Avista Capital Partners , a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding
Toggle Summary Express Scripts Holding Company Announces 2018 Financial Guidance Conference Call
ST. LOUIS , Nov. 9, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) today announced its intention to release its 2018 financial guidance on Thursday, December 14, 2017 , via press release before the market opens, followed by a conference call to discuss the 2018 financial
Toggle Summary Express Scripts Recognized as a Best Place to Work for LGBTQ Equality
ST. LOUIS , Nov. 9, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) has received a perfect score of 100 on the 2018 Corporate Equality Index, a national benchmarking report on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality,
Toggle Summary Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS , Oct. 30, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the Credit Suisse Annual Healthcare Conference on Tuesday, November 7, 2017 at 9:45 a.m. MST ( 11:45 a.m.
Toggle Summary Express Scripts Appoints James M. Havel Chief Financial Officer
ST. LOUIS , Oct. 24, 2017 /PRNewswire/ --  Express Scripts Holding Company (NASDAQ: ESRX) today announced that James M. Havel , who previously served as Express Scripts' Executive Vice President, has been named Executive Vice President and Chief Financial Officer, effective October 25, 2017 .
Toggle Summary Express Scripts Announces 2017 Third Quarter Results
ST. LOUIS , Oct. 24, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 third quarter net income of $841.7 million or $1.46 per diluted share.  2017 third quarter adjusted earnings per diluted share was $1.90 .*   "We have taken significant steps forward this year
Toggle Summary New Research: Affordability and Access to Prescription Medications Take Center Stage in Selecting a Medicare Plan
ST. LOUIS , Oct. 18, 2017 /PRNewswire/ -- Medicare can be an alphabet soup (Part D; MA-PD; MA), but according to research released today by Express Scripts (NASDAQ: ESRX), seniors understand the value offered by these plans, especially when it comes to prescription medications.
Toggle Summary Express Scripts to Acquire eviCore healthcare; Accelerates Company's Shift to Patient Benefit Management
- Improves ability to address $1 trillion annually wasted on unnecessary healthcare spending - Establishes cornerstone platform to rapidly advance into Medical Benefits Management Services, a large and growing market - Creates a comprehensive suite of data-driven service solutions with
Toggle Summary A New Normal? 870,000 Americans Used $50,000 Worth or More of Prescription Medicine in 2016
- New Express Scripts research shows in 2016, an estimated 870,000 Americans reached or exceeded a yearly medication cost threshold of $50,000, up 35 percent from 2014. - Less than one-third of one percent of the U.S. population accounted for an estimated $80 billion of total U.S. drug spending.
Toggle Summary Express Scripts Introduces New Medicare Part D Saver Plan for 2018
New Saver Plan offers a low monthly premium and a preferred pharmacy network featuring CVS Pharmacy and Kroger. ST. LOUIS , Oct. 2, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today introduced a new Express Scripts Medicare ® Prescription Drug Plan (PDP) for 2018 called the Saver plan, a
Toggle Summary Express Scripts Offers Important Prescription Drug Information for Residents Impacted by Hurricane Irma
ST. LOUIS , Sept. 7, 2017 /PRNewswire/ -- Express Scripts is providing the following information to assist residents impacted by Hurricane Irma in Florida , Georgia and Puerto Rico who have prescription coverage through Express Scripts . WHO:  All people who have a pharmacy benefit administered by
Toggle Summary Express Scripts Holding Company Announces Third Quarter 2017 Earnings Conference Call
St. Louis , Sept. 05, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 third quarter financial results on Tuesday, October 24, 2017 after the market closes and will hold its quarterly conference call to
Toggle Summary Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS , Aug. 30, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the 2017 Wells Fargo Healthcare Conference on Wednesday, September 6, 2017 at 9:05 a.m. eastern ( 8:05 a.m. central).
Toggle Summary Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications
ST. LOUIS , Aug. 25, 2017 /PRNewswire/ -- New research released today by Express Scripts (NASDAQ: ESRX) reveals that commercially insured people who were adherent to their oral diabetes medications experienced significantly fewer emergency room visits and inpatient hospitalizations, and spent
Toggle Summary Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS , Aug. 23, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) was recognized today as a top-scoring company on the Disability Equality Index® (DEI) for having inclusive workplace, social and governance policies. The DEI is a national benchmarking tool and joint initiative of the
Toggle Summary Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS , Aug. 23, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) was recognized today as a top-scoring company on the Disability Equality Index® (DEI) for having inclusive workplace, social and governance policies. The DEI is a national benchmarking tool and joint initiative of the
Toggle Summary The Value of Active Pharmacy Management: Express Scripts 2018 National Preferred Formulary
ST. LOUIS , July 31, 2017 Deciding which medicines to include on the nation's largest drug list starts where it should: by determining which medicines deliver the best outcomes for patients. Experience the interactive Multichannel News Release here:
Toggle Summary Express Scripts Announces 2017 Second Quarter Results
ST. LOUIS , July 25, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 second quarter net income of $801.8 million or $1.37 per diluted share.  2017 second quarter adjusted earnings per diluted share was $1.73 .*   "We leverage the power and potential of our
Toggle Summary Express Scripts Holding Company Announces Second Quarter 2017 Earnings Conference Call
St. Louis , July 06, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 second quarter financial results on Tuesday, July 25, 2017 after the market closes and will hold its quarterly conference call to
Toggle Summary Express Scripts Elects Kathleen M. Mazzarella to Board of Directors
ST. LOUIS , June 27, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) today announced the election of Kathleen M. Mazzarella to the company's Board of Directors effective June 27 , 2017.  "We are honored that Kathy will be joining our Board, and we appreciate the wealth of
Toggle Summary A Nation in Pain: Focus on Medicaid
ST. LOUIS , June 22, 2017 /PRNewswire/ -- Our nation's unprecedented opioid epidemic has been called the worst drug crisis in American history. To highlight the severity of this issue, consider these few alarming statistics: Drug overdose now leads the cause of accidental deaths in the United
Toggle Summary Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse
ST. LOUIS , June 7, 2017 /PRNewswire/ -- Building upon its history of industry-leading bold actions, Express Scripts (NASDAQ: ESRX) today announced a new Advanced Opioid Management SM solution that will better address our nation's opioid-addiction epidemic by working comprehensively with patients,
Toggle Summary Express Scripts Holding Company to Present at Upcoming Conferences
ST. LOUIS , June 5, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at two upcoming conferences: Goldman Sachs 38 th Annual Global Healthcare Conference on Tuesday, June 13, 2017 at 9:20 a.m. pacific ( 12:20 p.m.
Toggle Summary Express Scripts Expands SafeGuardRx® Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis
- Pulmonary Care Value Program addresses medication adherence through remote patient monitoring, patient engagement via Express Scripts' exclusive collaboration with Mango Health, and a quality pharmacy network. - Multiple Sclerosis Care Value Program shields payers from costs associated with
Toggle Summary Express Scripts Subsidiary to Join Walgreens Boots Alliance Development Group Purchasing Organization
ST. LOUIS , May 18, 2017 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX), through a wholly owned subsidiary, Innovative Product Alignment, LLC , today announced it will participate in Walgreens Boots Alliance Development GmbH (WBAD) group purchasing organization.
Toggle Summary Express Scripts and myMatrixx Combine To Offer Best-in-Class Pharmacy Services for Workers' Compensation Programs
ST. LOUIS , May 17, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) today announced it is taking an important step in expanding its customized workers' compensation pharmacy solutions by acquiring myMatrixx, a pharmacy benefit solutions provider for the workers' compensation industry. The
Toggle Summary Express Scripts Holding Company to Present at an Upcoming Conference
ST. LOUIS , May 8, 2017 /PRNewswire/ --   Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16, 2017 at 11:20 a.m. pacific ( 2:20 p.m.
Toggle Summary Cross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs
Inside Rx, a new initiative from Express Scripts, partners with GoodRx, drug manufacturers and drug stores to save Americans an average of 34 percent at 40,000 pharmacies ST. LOUIS and SANTA MONICA, Calif. , May 8, 2017 /PRNewswire/ -- Today, Express Scripts (NASDAQ: ESRX) announced the launch of 
Toggle Summary Express Scripts Recognized Among Most Diverse U.S. Companies by DiversityInc
ST. LOUIS , May 5, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) has been recognized by DiversityInc as a "Noteworthy" company for diversity, based on its hiring, retention, and promotion of women, minorities, people with disabilities, LGBT individuals, and veterans.
Toggle Summary Express Scripts Announces 2017 First Quarter Results; Provides Update on Anthem Relationship and Visibility into Core PBM Business Excluding Contribution from Anthem, Coventry and Catamaran
ST. LOUIS , April 24, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 first quarter net income of $546.3 million or $0.90 per diluted share.  The 2017 first quarter adjusted earnings per diluted share was $1.33 .*   First Quarter 2017 Results The following
Toggle Summary Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call
St. Louis , April 11, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 first quarter financial results on Monday, April 24, 2017 after the market closes and will hold its quarterly conference call to
Toggle Summary U.S. Workers' Compensation Prescription Drug Spending Decreased 7.6% in 2016 Through Cost-Savings Solutions, Improved Care for Injured Workers
ST. LOUIS , April 4, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) lowered prescription drug spending for workers' compensation payers by 7.6 percent in 2016, according to the 11 th edition of its Workers' Compensation Drug Trend Report. "In a year when many payers wrestled with drug price
Toggle Summary Mango Health Announces Partnership, Strategic Investment from Express Scripts
New daily health solution connects two industry leading platforms for improving health outcomes and reducing the cost of care. SAN FRANCISCO , March 15, 2017 /PRNewswire-USNewswire/ -- Mango Health , a mobile health company, today announced a long term operating partnership with Express Scripts
Toggle Summary Express Scripts Holding Company to Present at the Barclays Global Healthcare Conference
ST. LOUIS , March 7, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 9:30 a.m. Eastern Daylight Time at the Loews Miami Beach Hotel in Miami
Toggle Summary High Drug Prices Frustrate Government-Sponsored Health Programs, According to New Express Scripts Drug Trend Insights
ST. LOUIS , Feb. 28, 2017 /PRNewswire/ -- Health plans partnering with Express Scripts are delivering high-quality, affordable pharmacy care to millions of individuals enrolled in government-sponsored programs, but this record is at risk without decisive action to advance additional pro-patient and
Toggle Summary Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017
ST. LOUIS , Feb. 16, 2017 /PRNewswire/ --  Express Scripts (NASDAQ: ESRX) was recognized today by Fortune Magazine as one of the World's Most Admired Companies within the Health Care: Pharmacy and Other Services category. " Express Scripts is honored to be named one of the World's Most Admired
Toggle Summary Express Scripts Announces 2016 Fourth Quarter and Full Year Results
ST. LOUIS , Feb. 14, 2017 /PRNewswire/ --  Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 fourth quarter and full year net income of $1,434.7 million and $3,404.4 million , respectively, or $2.34 and $5.39 per diluted share, respectively.  2016 fourth quarter and full year adjusted
Toggle Summary Express Scripts Fights Back Against Irresponsible Drug Pricing; Holds U.S. Drug Spending Increase to 3.8 Percent in 2016
- Patients' share of cost for prescription drugs declined for the second consecutive year - Despite brand-name list price increases of nearly 11 percent, Express Scripts kept unit cost increases for employers to just 2.5 percent across all prescription drugs - One-third of employers with pharmacy
Toggle Summary Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call
ST. LOUIS , Jan. 18, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) (“ Express Scripts ”) announced today its intention to release its 2016 fourth quarter and full year financial results on Tuesday, February 14, 2017 after the market closes and will hold its quarterly
Toggle Summary Express Scripts Holding Company to Present at the J.P. Morgan Healthcare Conference
ST. LOUIS , Jan. 4, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today that it will present at the J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 11:30 a.m. Pacific Time ( 2:30 p.m. EST ) at the Westin St.